Issued 2026-09-25 at $3.08 · now $3.08 (2026-09-25, +0.0% since)
Based on its own history, a month from the 2026-09-25 close, LRMR has typically landed between $2.13 and $4.53 — a range of −30.7% to +47.2% from the issuance price $3.08.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
3,062 overlapping 1 month windows · 2014-06-19 – 2026-08-26 · basis climatology · forecast (batch). Base rate up 53.7% (90% CI 51.5–55.9%, ≈1,391 obs). Not a call on this stock — we have no evidence its odds differ.
The cone is anchored at the 2026-09-25 issuance close ($3.08) — the price the forecast resolves against on 2026-10-26, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where LRMR has typically landed a month from the 2026-09-25 close of $3.08 — the range is history, not a prediction.
- now $3.08 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $3.01 (-2.2%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $2.51–$3.51
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $2.13–$4.53
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2015-09-17 | −76.3% | −76.3% | +5.6% |
| 2015-09-23 | −75.6% | −76.3% | +0.0% |
| 2015-09-22 | −75.2% | −76.1% | +1.2% |
| 3 best | |||
| 2024-01-17 | +215.4% | +0.0% | +215.4% |
| 2024-01-18 | +194.5% | −1.8% | +206.0% |
| 2024-01-16 | +184.8% | +0.0% | +184.8% |
3,062 overlapping windows · 2014-06-19 – 2026-09-25 · not cherry-picked
Pending catalysts
- January 2027 — Trial primary completion: Phase 2 primary completion: An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia (source, as of 2026-08-14)
Public, scheduled events — dated attention, not a prediction of the outcome. See the FDA catalysts page for the historical base rate.
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~13 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-06 | Hamilton Thomas Edward | director | Purchase | 50,000 @ $3.34 | $167K | +7.5% of holding | +22.3% | not yet — horizon still open | 714,798 | Form 4 · filed 2 days after the trade |
| 2026-02-27 | Flynn James E | director | Purchase | 2,000,000 @ $5.00 | $10.0M | +47.5% of holding | −11.2% | −37.2% | 6,207,982 | Form 4 · filed 3 days after the trade |
| 2026-02-27 | Flynn James E | director | Purchase | 1,084,012 @ $5.00 | $5.4M | +11.4% of holding | −11.2% | −37.2% | 10,622,957 | Form 4 · filed 3 days after the trade |
| 2026-02-27 | Flynn James E | director | Purchase | 1,084,010 @ $5.00 | $5.4M | +11.4% of holding | −11.2% | −37.2% | 10,622,928 | Form 4 · filed 3 days after the trade |
| 2026-02-27 | Flynn James E | director | Purchase | 831,978 @ $5.00 | $4.2M | +11.4% of holding | −11.2% | −37.2% | 8,153,107 | Form 4 · filed 3 days after the trade |
| 2026-02-27 | Hamilton Thomas Edward | director | Purchase | 100,000 @ $5.00 | $500K | +17.7% of holding | −11.2% | −37.2% | 664,798 | Form 4 · filed 3 days after the trade |
| 2026-02-27 | THOMAS FRANK E | director | Purchase | 5,000 @ $5.00 | $25K | +250.0% of holding | −11.2% | −37.2% | 7,000 | Form 4 · filed 3 days after the trade |
| 2026-02-27 | SHERMAN JEFFREY W | director | Purchase | 5,000 @ $5.00 | $25K | ownership Δ n/a | −11.2% | −37.2% | 5,000 | Form 4 · filed 3 days after the trade |
| 2025-07-31 | Flynn James E | director | Purchase | 3,387,539 @ $3.20 | $10.8M | +55.1% of holding | +2.6% | −7.8% | 9,538,945 | Form 4 · filed 4 days after the trade |
| 2025-07-31 | Flynn James E | director | Purchase | 3,387,529 @ $3.20 | $10.8M | +55.1% of holding | +2.6% | −7.8% | 9,538,918 | Form 4 · filed 4 days after the trade |
| 2025-07-31 | Flynn James E | director | Purchase | 2,599,932 @ $3.20 | $8.3M | +55.1% of holding | +2.6% | −7.8% | 7,321,129 | Form 4 · filed 4 days after the trade |
| 2024-02-16 | Flynn James E | director | Purchase | 1,430,206 @ $8.74 | $12.5M | +30.3% of holding | −36.3% | −51.0% | 6,151,389 | Form 4 · filed same day |
| 2024-02-16 | Flynn James E | director | Purchase | 1,430,206 @ $8.74 | $12.5M | +30.3% of holding | −36.3% | −51.0% | 6,151,406 | Form 4 · filed same day |
| 2024-02-16 | Flynn James E | director | Purchase | 1,430,205 @ $8.74 | $12.5M | +51.5% of holding | −36.3% | −51.0% | 4,207,982 | Form 4 · filed same day |
| 2024-02-16 | Hamilton Thomas Edward | director | Purchase | 57,208 @ $8.74 | $500K | +11.3% of holding | −36.3% | −51.0% | 564,798 | Form 4 · filed 105 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
34 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-05-19 | Flynn James E | director | Award / grant | 55,150 | 55,150 | Form 4 |
| 2026-05-19 | LEFF JONATHAN S | director | Award / grant | 55,150 | 55,150 | Form 4 |
| 2026-05-19 | THOMAS FRANK E | director | Award / grant | 55,150 | 55,150 | Form 4 |
| 2026-05-19 | Truitt Joseph | director | Award / grant | 55,150 | 55,150 | Form 4 |
| 2026-05-19 | SHERMAN JEFFREY W | director | Award / grant | 55,150 | 55,150 | Form 4 |
| 2026-05-19 | Hamilton Thomas Edward | director | Award / grant | 55,150 | 55,150 | Form 4 |
| 2026-01-26 | BEN-MAIMON CAROLE | director | Award / grant | 600,600 | 600,600 | Form 4 |
| 2026-01-26 | Celano Michael | officer | Award / grant | 37,604 | 215,785 | Form 4 |
| 2026-01-26 | Celano Michael | officer | Award / grant | 225,622 | 225,622 | Form 4 |
| 2026-01-26 | Clayton Russell | officer | Award / grant | 153,822 | 153,822 | Form 4 |
| 2026-01-26 | Shankar Gopi | officer | Award / grant | 25,637 | 76,443 | Form 4 |
| 2026-01-26 | Shankar Gopi | officer | Award / grant | 153,822 | 153,822 | Form 4 |
| 2026-01-26 | Clayton Russell | officer | Award / grant | 25,637 | 71,443 | Form 4 |
| 2026-01-26 | BEN-MAIMON CAROLE | director | Award / grant | 100,100 | 368,276 | Form 4 |
| 2025-05-13 | THOMAS FRANK E | director | Award / grant | 19,000 | 19,000 | Form 4 |
| 2025-05-13 | Truitt Joseph | director | Award / grant | 19,000 | 19,000 | Form 4 |
| 2025-05-13 | Flynn James E | director | Award / grant | 19,000 | 19,000 | Form 4 |
| 2025-05-13 | LEFF JONATHAN S | director | Award / grant | 19,000 | 19,000 | Form 4 |
| 2025-05-13 | Hamilton Thomas Edward | director | Award / grant | 19,000 | 19,000 | Form 4 |
| 2025-05-13 | SHERMAN JEFFREY W | director | Award / grant | 19,000 | 19,000 | Form 4 |
| 2025-01-22 | Clayton Russell | officer | Award / grant | 139,838 | 139,838 | Form 4 |
| 2025-01-22 | BEN-MAIMON CAROLE | director | Award / grant | 546,000 | 546,000 | Form 4 |
| 2025-01-22 | BEN-MAIMON CAROLE | director | Award / grant | 91,000 | 387,208 | Form 4 |
| 2025-01-22 | Celano Michael | officer | Award / grant | 34,185 | 178,181 | Form 4 |
| 2025-01-22 | Celano Michael | officer | Award / grant | 205,111 | 205,111 | Form 4 |
| 2025-01-22 | Shankar Gopi | officer | Award / grant | 23,306 | 50,806 | Form 4 |
| 2025-01-22 | Shankar Gopi | officer | Award / grant | 139,838 | 139,838 | Form 4 |
| 2025-01-22 | Clayton Russell | officer | Award / grant | 23,306 | 45,806 | Form 4 |
| 2024-05-29 | Flynn James E | director | Award / grant | 19,000 | 19,000 | Form 4 |
| 2024-05-29 | Hamilton Thomas Edward | director | Award / grant | 19,000 | 19,000 | Form 4 |
| 2024-05-29 | THOMAS FRANK E | director | Award / grant | 19,000 | 19,000 | Form 4 |
| 2024-05-29 | Truitt Joseph | director | Award / grant | 19,000 | 19,000 | Form 4 |
| 2024-05-29 | SHERMAN JEFFREY W | director | Award / grant | 19,000 | 19,000 | Form 4 |
| 2024-05-29 | LEFF JONATHAN S | director | Award / grant | 19,000 | 19,000 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.